Using the GEPIA database, we found that high YAP1 expression levels were associated with a poorer prognosis based on OS and disease-free survival (DFS) in pancreatic cancer (OS, HR = 1.8, p = 0.0053; DFS HR = 1.9, p = 0.043) but not in gastric cancer (OS, HR = 0.85, p = 0.49; DFS, HR = 0.74, p = 0.29) (Figure 5K,L,G,H). Here, YAP1 is linked to gastric cancer.